Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Koistinaho, Milla, Lin, Suizhen, Wu, Xin, Esterman, Michail, Koger, Deanna, Hanson, Jeffrey, Higgs, Richard, Liu, Feng +3 more·2004·Nature Medicine
DOI 10.1038/nm1058

Cited by (569)

Items 101–200 of 569

  1. Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease
    Serrano-Pozo, Alberto, Muzikansky, Alona, Gómez-Isla, Teresa, Growdon, John H., Betensky, Rebecca A., Frosch, Matthew P., Hyman, Bradley T. · 2013 · Journal of Neuropathology & Experimental Neurology
  2. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades
    Marco Matos, Elisabete Augusto, Catarina Resende Oliveira, Paula M. Agostinho · 2008 · Neuroscience
  3. LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
    Takahisa Kanekiyo, Chia‐Chen Liu, Mitsuru Shinohara, Jie Li, Guojun Bu · 2012 · Journal of Neuroscience
  4. Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation
    Jill A. White, Arlene M. Manelli, Kristina H. Holmberg, Linda J. Van Eldik, Mary Jo LaDu · 2005 · Neurobiology of Disease
  5. Astrocytic dysfunction: Insights on the role in neurodegeneration
    Daniela Rossi, Andrea Volterra · 2009 · Brain Research Bulletin
  6. Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer’s Disease by Accelerating the Clearance of Amyloid-Beta
    Song, Qingxiang, Huang, Meng, Yao, Lei, Wang, Xiaolin, Gu, Xiao, Chen, Juan, Chen, Jun, Huang, Jialin, Hu, Quanyin, Kang, Ting et al. · 2014 · ACS Nano
  7. The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer's Brain and Retinal Disease
    Jeremy M. Sivak · 2013 · Investigative Ophthalmology & Visual Science
  8. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
    Farfara, D., Lifshitz, V., Frenkel, D. · 2008 · Journal of Cellular and Molecular Medicine
  9. Metabolism of amyloid-β peptide and Alzheimer's disease
    Nobuhisa Iwata, Makoto Higuchi, Takaomi C. Saido · 2005 · Pharmacology & Therapeutics
  10. Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke
    Adjanie Patabendige, Ayesha Singh, Stuart Iain Jenkins, Jon Sen, Ruoli Chen · 2021 · International Journal of Molecular Sciences
  11. The “Neuro-Glial-Vascular” Unit: The Role of Glia in Neurovascular Unit Formation and Dysfunction
    Elisabeth Kugler, John Greenwood, Ryan B. MacDonald · 2021 · Frontiers in Cell and Developmental Biology
  12. APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Uddin, Md. Sahab, Kabir, Md. Tanvir, Al Mamun, Abdullah, Abdel-Daim, Mohamed M., Barreto, George E., Ashraf, Ghulam Md · 2019 · Molecular Neurobiology
  13. Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
    Huynh, Tien-Phat V., Davis, Albert A., Ulrich, Jason D., Holtzman, David M. · 2017 · Journal of Lipid Research
  14. Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease
    Dodart, Jean-Cosme, Marr, Robert A., Koistinaho, Milla, Gregersen, Beth M., Malkani, Seema, Verma, Inder M., Paul, Steven M. · 2005 · Proceedings of the National Academy of Sciences
  15. <i>Chi3l1</i> /YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer’s disease pathogenesis
    Lananna, Brian V., McKee, Celia A., King, Melvin W., Del-Aguila, Jorge L., Dimitry, Julie M., Farias, Fabiana H. G., Nadarajah, Collin J., Xiong, David D., Guo, Chun, Cammack, Alexander J. et al. · 2020 · Science Translational Medicine
  16. Apolipoproteins in the brain: implications for neurological and psychiatric disorders
    David A. Elliott, Cynthia Shannon Weickert, Brett Garner · 2010 · Clinical Lipidology
  17. Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes
    Basak, Jacob M., Verghese, Philip B., Yoon, Hyejin, Kim, Jungsu, Holtzman, David M. · 2012 · Journal of Biological Chemistry
  18. The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
    Cody M. Wolfe, Nicholas Francis Fitz, Kyong Nyon Nam, Iliya M. Lefterov, Radosveta P. Koldamova · 2018 · International Journal of Molecular Sciences
  19. Autophagy and ALS: mechanistic insights and therapeutic implications
    Chua, Jason P., De Calbiac, Hortense, Kabashi, Edor, Barmada, Sami J. · 2022 · Autophagy
  20. Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer’s pathology and APOE genotype
    Julie E. Simpson, Paul G. Ince, Pamela J. Shaw, Paul Roy Heath, Rohini Raman, Claire J. Garwood, Catherine Gelsthorpe, Lynne Baxter, Gillian Forster, Fiona E. Matthews et al. · 2011 · Neurobiology of Aging
  21. Understanding the Amyloid Hypothesis in Alzheimer’s Disease
    Giulia Paroni, Paola Bisceglia, Davide Seripa · 2019 · Journal of Alzheimer s Disease
  22. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
    Najm, Ramsey, Jones, Emily A., Huang, Yadong · 2019 · Molecular Neurodegeneration
  23. Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice
    Grainger, David J, Reckless, Jill, McKilligin, Elaine · 2004 · The Journal of Immunology
  24. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
    Roger M. Lane, Martin Rhys Farlow · 2005 · Journal of Lipid Research
  25. Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives
    Seung‐Jae Lee, Hee-Sun Lim, Eliezer Masliah, He-Jin Lee · 2011 · Neuroscience Research
  26. Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function
    Shu-Ming Huang, Akihiro Mouri, Hideko Kokubo, Ryuichi Nakajima, Takahiro Suemoto, Makoto Higuchi, Matthias Staufenbiel, Yukihiro Noda, Haruyasu Yamaguchi, Toshitaka Nabeshima et al. · 2006 · Journal of Biological Chemistry
  27. Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death
    Daniela Rossi · 2015 · Progress in Neurobiology
  28. Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice
    Bien-Ly, Nga, Gillespie, Anna K., Walker, David, Yoon, Seo Yeon, Huang, Yadong · 2012 · The Journal of Neuroscience
  29. Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimers Disease
    Lingfei Ruan, Zhoujun Kang, Gang Pei, Yingying Le · 2009 · Current Alzheimer Research
  30. Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples*
    Tai, Leon M., Bilousova, Tina, Jungbauer, Lisa, Roeske, Stephen K., Youmans, Katherine L., Yu, Chunjiang, Poon, Wayne W., Cornwell, Lindsey B., Miller, Carol A., Vinters, Harry V. et al. · 2013 · Journal of Biological Chemistry
  31. The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease
    Naoyuki Sato, Ryuichi Morishita · 2015 · Frontiers in Aging Neuroscience
  32. Astrocytic Aβ1‐42 uptake is determined by Aβ‐aggregation state and the presence of amyloid‐associated proteins
    Henrietta M. Nielsen, Sandra D. Mulder, Jeroen A.M. Beliën, René J.P. Musters, Piet Eikelenboom, Robert Veerhuis · 2010 · Glia
  33. Apolipoprotein E and Alzheimer's disease
    Benjamin Troutwine, Laylan Hamid, Colton R Lysaker, Taylor A. Strope, Heather Wilkins · 2021 · Acta Pharmaceutica Sinica B
  34. Transplanted astrocytes internalize deposited β‐amyloid peptides in a transgenic mouse model of Alzheimer's disease
    Rea Pihlaja, Jari Koıstınaho, Tarja Malm, Herkko Sikkilä, Seppo Juhani Vainio, Milla Koistinaho · 2007 · Glia
  35. Differential SUMOylation of LXRα and LXRβ Mediates Transrepression of STAT1 Inflammatory Signaling in IFN-γ-Stimulated Brain Astrocytes
    Lee, Jee Hoon, Park, Sang Myun, Kim, Ohn Soon, Lee, Chang Seok, Woo, Joo Hong, Park, Soo Jung, Joe, Eun-hye, Jou, Ilo · 2009 · Molecular Cell
  36. Neural cell cycle dysregulation and central nervous system diseases
    Wei Wang, Bitao Bu, Minjie Xie, Min Zhang, Zhiyuan Yu, Deding Tao · 2009 · Progress in Neurobiology
  37. Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death
    Lishu Duan, Bula J. Bhattacharyya, Abdelhak A. Belmadani, Liuliu Pan, Richard J. Miller, John A. Kessler · 2014 · Molecular Neurodegeneration
  38. Glia in the pathogenesis of neurodegenerative diseases
    Alexei Verkhratsky, Vladimir Parpura, Marcela Pekna, Milos Pekny, Michael V. Sofroniew · 2014 · Biochemical Society Transactions
  39. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation.
    S. Vesce, D. Rossi, L. Brambilla, A. Volterra · 2007 · International review of neurobiology
  40. Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research
    Abinaya Chandrasekaran, Hasan X. Avci, Marcel Leist, Julianna Kobolák, András Dinnyés · 2016 · Frontiers in Cellular Neuroscience
  41. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease
    Zhao, Ruohe, Hu, Wanling, Tsai, Julia, Li, Wei, Gan, Wen-Biao · 2017 · Molecular Neurodegeneration
  42. “Targeting astrocytes in CNS injury and disease: A translational research approach”
    Angela R. Filous, Jerry Silver · 2016 · Progress in Neurobiology
  43. Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
    Md. Sahab Uddin, Lee Wei Lim · 2022 · Ageing Research Reviews
  44. Interactions between Alzheimer's disease and cerebral ischemia—focus on inflammation
    Milla Koistinaho, Jari Koıstınaho · 2005 · Brain Research Reviews
  45. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer’s disease model
    Marius Krauthausen, Markus P. Kummer, Julian Zimmermann, Elisabet Reyes-Irisarri, Dick Terwel, Bruno Bulic, Michael Thomas Heneka, Marcus Müller · 2014 · Journal of Clinical Investigation
  46. Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
    Abhay P. Sagare, Robert D. Bell, Berislav V. Zloković · 2012 · Journal of Alzheimer s Disease
  47. Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities
    Abhay P. Sagare, Rashid Deane, Berislav V. Zloković · 2012 · Pharmacology & Therapeutics
  48. Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease
    Hervé Rhinn, Ryousuke Fujita, Liang Qiang, Rong Cheng, Joseph Hyungwoo Lee, Asa Abeliovich · 2013 · Nature · Retracted
  49. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance
    Géraldine Gontier, Caroline George, Zayna Chaker, Martin Holzenberger, Saba Aïd · 2015 · Journal of Neuroscience
  50. Characteristics of Aquaporin Expression Surrounding Senile Plaques and Cerebral Amyloid Angiopathy in Alzheimer Disease
    Akihiko Hoshi, Teiji Yamamoto, Keiko Shimizu, Yoshikazu Ugawa, Masatoyo Nishizawa, Hitoshi Takahashi, Akiyoshi Kakita · 2012 · Journal of Neuropathology & Experimental Neurology
  51. The role of astrocytes in amyloid β-protein toxicity and clearance
    Dietmar Rudolf Thal · 2012 · Experimental Neurology
  52. Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice
    Lauren M. Billings, Kim N. Green, James Lafayette McGaugh, Frank M. LaFerla · 2007 · Journal of Neuroscience
  53. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β
    Masayuki Morikawa, John Denis Fryer, Patrick M. Sullivan, Erin Christopher, Suzanne E. Schindler, Ronald Bradley Demattos, Mark Odell, Anne M. Fagan, Hilal Ahmed Lashuel, Thomas Walz et al. · 2005 · Neurobiology of Disease
  54. Emerging Roles of Astrocytes in Neuro-Vascular Unit and the Tripartite Synapse With Emphasis on Reactive Gliosis in the Context of Alzheimer’s Disease
    Liu, Cai-Yun, Yang, Yu, Ju, Wei-Na, Wang, Xu, Zhang, Hong-Liang · 2018 · Frontiers in Cellular Neuroscience
  55. Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
    Raquel Maria Sanchez-Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, Cristina Nuñez‐Diaz, Laura Cáceres-Palomo, Laura Vegas‐Gomez, Elisabeth Sánchez‐Mejías, Laura Trujillo‐Estrada, Juan Antonio García‐León, Inés Moreno‐González et al. · 2022 · International Journal of Molecular Sciences
  56. Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy
    Verica Vasić, Kathrin Barth, Mirko H. H. Schmidt · 2019 · International Journal of Molecular Sciences
  57. Diversity of astroglial responses across human neurodegenerative disorders and brain aging
    Isidró Ferrer · 2017 · Brain Pathology
  58. Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease
    Micha M.M. Wilhelmus, Robert M.W. de Waal, Marcel M. Verbeek · 2007 · Molecular Neurobiology
  59. The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells
    Kaoru Yamada, Tadafumi Hashimoto, Chiori Yabuki, Yusuke Nagae, Masanori Tachikawa, Dudley K. Strickland, Qiang Liu, Guojun Bu, Jacob M. Basak, David M. Holtzman et al. · 2008 · Journal of Biological Chemistry
  60. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
    Liraz, Ori, Boehm-Cagan, Anat, Michaelson, Daniel M · 2013 · Molecular Neurodegeneration
  61. Disease modifying therapy for AD?<sup>1</sup>
    Golde, Todd E. · 2006 · Journal of Neurochemistry
  62. Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis
    Mahua Maulik, David A. Westaway, Jack H. Jhamandas, Satyabrata Kar · 2012 · Molecular Neurobiology
  63. Phagocytic Clearance in Neurodegeneration
    Jennifer D. Sokolowski, James William Mandell · 2011 · American Journal Of Pathology
  64. Microglia-Astrocyte Communication in Alzheimer’s Disease
    Yingying Wu, Ulrich L.M. Eisel · 2023 · Journal of Alzheimer s Disease
  65. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
    Tai, Leon M, Mehra, Shipra, Shete, Varsha, Estus, Steve, Rebeck, G William, Bu, Guojun, LaDu, Mary Jo · 2014 · Molecular Neurodegeneration
  66. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease
    Shinohara, Mitsuru, Fujioka, Shinsuke, Murray, Melissa E., Wojtas, Aleksandra, Baker, Matthew, Rovelet-Lecrux, Anne, Rademakers, Rosa, Das, Pritam, Parisi, Joseph E., Graff-Radford, Neill R. et al. · 2014 · Brain
  67. The effect of insomnia on development of Alzheimer’s disease
    Shaghayegh Sadeghmousavi, Mahsa Eskian, Farzaneh Rahmani, Nima Rezaei · 2020 · Journal of Neuroinflammation
  68. ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
    Shibuya, Yohei, Chang, Catherine CY, Chang, Ta-Yuan · 2015 · Future Medicinal Chemistry
  69. The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain
    Anne-Sophie Carlo, Camilla Gustafsen, Guido Mastrobuoni, Morten Schallburg Nielsen, Tilman Burgert, Daniela Hartl, Michael Rohe, Anders Nykjær, Joachim Herz, Jöerg Heeren et al. · 2013 · Journal of Neuroscience
  70. Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet
    Stephanie Seneff, Glyn Wainwright, Luca Mascitelli · 2011 · European Journal of Internal Medicine
  71. Astroglia as a cellular target for neuroprotection and treatment of neuro‐psychiatric disorders
    Beihui Liu, Anja G. Teschemacher, Sergey Kasparov · 2017 · Glia
  72. Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines
    Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivènyi, László Vécsei · 2018 · Journal of Alzheimer s Disease
  73. Extracellular Vesicle Biology in Alzheimer’s Disease and Related Tauopathy
    Annina M. DeLeo, Tsuneya Ikezu · 2017 · Journal of Neuroimmune Pharmacology
  74. Evidence of a Role for Lactadherin in Alzheimer's Disease
    Jacques Boddaert, Kiyoka Kinugawa, Jean‐Charles Lambert, Fatiha Boukhtouche, Joffrey Zoll, Régine Merval, Olivier Blanc‐Brude, David M. A. Mann, Claudine Berr, José Vilar et al. · 2007 · American Journal Of Pathology
  75. The role and therapeutic potential of monocytic cells in Alzheimer's disease
    Tarja Malm, Milla Koistinaho, Anu Muona, Johanna M. Magga, Jari Koıstınaho · 2010 · Glia
  76. Neurovascular Pathways and Alzheimer Amyloid β-peptide
    Zlokovic, Berislav V., Deane, Rashid, Sallstrom, Jan, Chow, Nienwen, Miano, Joseph M. · 2006 · Brain Pathology
  77. Quantitative Mass Spectrometry-based Proteomics Reveals the Dynamic Range of Primary Mouse Astrocyte Protein Secretion
    Todd M. Greco, Steven H. Seeholzer, Adrian Mak, Lynn A. Spruce, Harry Ischiropoulos · 2010 · Journal of Proteome Research
  78. ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.
    Woojin Jeong, Hyein G. Lee, Sukhee Cho, Jinsoo Seo · 2019 · PubMed Central
  79. Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease
    Thal, Dietmar Rudolf, Papassotiropoulos, Andreas, Saido, Takaomi C., Griffin, W. Sue T., Mrak, Robert E., Kölsch, Heike, Tredici, Kelly Del, Attems, Johannes, Ghebremedhin, Estifanos · 2010 · Acta Neuropathologica
  80. The impact of glial activation in the aging brain.
    Aileen M. Lynch, Kevin J Murphy, Brian F. Deighan, Julie-Ann O’Reilly, Yurii K. Gun’ko, Thelma R. Cowley, Rodrigo E. González-Reyes, Marina A. Lynch · 2010 · Europe PMC (PubMed Central)
  81. Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
    Mariana F. Uchoa, V. Alexandra Moser, Christian J. Pike · 2016 · Frontiers in Neuroendocrinology
  82. Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes
    Yi Cheng, Hideyuki Takeuchi, Yoshifumi Sonobe, Shijie Jin, Yue Wang, Hiroshi Horiuchi, Bijay Parajuli, Jun Kawanokuchi, Tetsuya Mizuno, Akio Suzumura · 2014 · Journal of Neuroimmunology
  83. Blood–brain barrier and blood–cerebrospinal fluid barrier in normal and pathological conditions
    Masaki Ueno, Yoichi Chiba, Ryuta Murakami, Koichí Matsumoto, Machi Kawauchi, Ryuji Fujihara · 2016 · Brain Tumor Pathology
  84. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
    López González, Irene, Garcia-Esparcia, Paula, Llorens, Franc, Ferrer, Isidre · 2016 · International Journal of Molecular Sciences
  85. Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin
    Jana Dimitrova Tchekalarova, Rumiana Tzoneva · 2023 · International Journal of Molecular Sciences
  86. The Proteasome and Oxidative Stress in Alzheimer's Disease
    Bonet-Costa, Vicent, Pomatto, Laura Corrales-Diaz, Davies, Kelvin J. A. · 2016 · Antioxidants &amp; Redox Signaling
  87. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
    Evan Dorey, Nina Chang, Qing Yan Liu, Ze Yang, Wandong Zhang · 2014 · Neuroscience Bulletin
  88. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
    Johanna M. Magga, Lakshman Puli, Rea Pihlaja, Katja M. Kanninen, Suvi Neulamaa, Tarja Malm, Wolfgang Härtig, Jens Grosche, Gundars Goldsteins, Heikki Tanila et al. · 2010 · Journal of Neuroinflammation
  89. The HSPB8‐BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases
    Kay Seidel, Jonathan Vinet, Wilfred F.A. den Dunnen, Ewout R. P. Brunt, Melanie Meister, Alessandra Boncoraglio, Marianne P. Zijlstra, H. W. G. M. Boddeke, Udo Rüb, Harm H. Kampinga et al. · 2011 · Neuropathology and Applied Neurobiology
  90. Microglia and astrocyte involvement in neurodegeneration and brain cancer
    Arthur A. Vandenbark, Halina Offner, Szymon Matejuk, Agata Matejuk · 2021 · Journal of Neuroinflammation
  91. Greasing the wheels of Aβ clearance in Alzheimer's Disease: The role of lipids and apolipoprotein E
    Fan, Jianjia, Donkin, James, Wellington, Cheryl · 2009 · BioFactors
  92. Binding and uptake of Aβ1‐42 by primary human astrocytes <i>in vitro</i>
    Nielsen, Henrietta M., Veerhuis, Robert, Holmqvist, Bo, Janciauskiene, Sabina · 2009 · Glia
  93. Multiple cellular and molecular mechanisms Are involved in human Aβ clearance by transplanted adult astrocytes
    Pihlaja, Rea, Koistinaho, Jari, Kauppinen, Riitta, Sandholm, Jouko, Tanila, Heikki, Koistinaho, Milla · 2011 · Glia
  94. Genetics of Alzheimer’s Disease
    Perry G. Ridge, Mark Ebbert, John S. K. Kauwe · 2013 · BioMed Research International
  95. Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
    Kang, Jihong, Rivest, Serge · 2012 · Endocrine Reviews
  96. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide
    Christopher S. Casley, Viktor Lakics, Hyoung‐gon Lee, Lisa M. Broad, Theresa A. Day, Tricia Cluett, Mark A. Smith, Michael J. O’Neill, Ann E. Kingston · 2009 · Brain Research
  97. Novel Luteolin-Loaded Chitosan Decorated Nanoparticles for Brain-Targeting Delivery in a Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
    Haidy Abbas, Nesrine S. El Sayed, Nancy Abdel Hamid Abou Youssef, Passent M.E. Gaafar, Mohamed R. Mousa, Ahmed M. Fayez, Manal A Elsheikh · 2022 · Pharmaceutics
  98. Amyloids: Friend or Foe?
    Neal D. Hammer, Xuan Wang, Bryan A. McGuffie, Matthew R. Chapman · 2008 · Journal of Alzheimer s Disease
  99. Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice
    Masaya Tachibana, Yu Yamazaki, Chia‐Chen Liu, Guojun Bu, Takahisa Kanekiyo · 2017 · Experimental Neurology
  100. Perivascular Unit: This Must Be the Place. The Anatomical Crossroad Between the Immune, Vascular and Nervous System
    Fernanda Troili, Virginia Cipollini, Marco Moci, Emanuele Morena, Miklós Palotai, Virginia Rinaldi, Carmela Romano, Giovanni Ristori, Franco Giubilei, Marco Salvetti et al. · 2020 · Frontiers in Neuroanatomy